Equillium Reports Third Quarter 2018 Financial Results and Recent Highlights
November 15, 2018 16:07 ET
|
Equillium, Inc.
Completes Successful Initial Public Offering Raising Gross Proceeds of Approximately $71.6 Million On-Track for Early 2019 Initiation of Phase 1b/2 Trial of EQ001 in Acute Graft-Versus-Host Disease ...
Equillium to Present at Investor Conferences in November 2018
November 01, 2018 16:07 ET
|
Equillium, Inc.
LA JOLLA, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe...
Equillium Announces Pricing of Initial Public Offering
October 12, 2018 08:25 ET
|
Equillium, Inc.
LA JOLLA, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Equillium Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune...
Adherium Announces Participation in SmartAirLA Effort to Combat Asthma in Los Angeles with Support from Blue Shield of California Foundation
October 03, 2018 06:00 ET
|
Adherium North America Inc
SAN MATEO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a leading digital health platform for medication adherence today announced its participation in the launch of the SmartAirLA...
SmartAirLA Awarded $250k to Pilot “Smart” Inhaler Program for Underserved Children in Los Angeles
October 03, 2018 06:00 ET
|
SmartAirLA
Part of Blue Shield of California Foundation’s $3.5 million grantmaking to assess the value of prevention in community health. LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Blue Shield of...
The Allergy Summit: Marketing To The Allergy Aware Consumer - The Value of Certification
October 01, 2018 09:25 ET
|
Allergy Standards Limited
New-York (NY), Oct. 01, 2018 (GLOBE NEWSWIRE) -- Brought to you by Allergy Standards Ltd (ASL) and The Asthma and Allergy Foundation of America (AAFA), The Allergy Summit is a unique event bringing...
University of Virginia Pairs Engineering with Medicine, Launching an Innovative Center that Generates New Ideas to Treat Diseases
September 13, 2018 10:31 ET
|
University of Virginia School of Engineering
Charlottesville, Va., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Recognizing that major breakthroughs in healthcare occur when engineering and medicine join forces, the University of Virginia has made a...
Allergy Standards Limited (ASL) announced today the appointment of Léa Daulan as Digital Marketing Manager.
July 31, 2018 07:30 ET
|
Allergy Standards Limited
Dublin, Ireland, July 31, 2018 (GLOBE NEWSWIRE) -- As Digital Marketing Manager, Léa will develop, implement and monitor ASL’s digital marketing strategy, primarily through social media, site...
Low-Odor Paint Offers a Healthier Solution for Your Home
July 27, 2018 09:58 ET
|
asthma & allergy friendly Certification Program
WASHINGTON, DC., July 27, 2018 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) has announced that EasyCare Ultra Premium Acrylic Latex...
GB Sciences Files Patent on Cannabis-based Therapies for the Treatment of Asthma, Urinary Cystitis, Hearing Loss, plus Chronic, Inflammatory and Neuropathic Pain
June 27, 2018 05:30 ET
|
GB Sciences, Inc.
Las Vegas, June 27, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) has filed a new provisional patent application on the use of cannabis-based therapies for the manipulation of...